Postsynaptic density-membrane associated guanylate kinase proteins (PSD-MAGUKs) and their role in CNS disorders
- PMID: 18773944
- DOI: 10.1016/j.neuroscience.2008.07.068
Postsynaptic density-membrane associated guanylate kinase proteins (PSD-MAGUKs) and their role in CNS disorders
Abstract
Membrane associated guanylate kinase proteins (MAGUKs) play a key role in the regulation of the intracellular trafficking and synaptic localization of ionotropic glutamate receptors. In particular, the postsynaptic density-95-like subfamily of MAGUKs (PSD-MAGUKs) organizes ionotropic glutamate receptors and their associated signaling proteins in the postsynaptic density of the excitatory synapse regulating the strength of synaptic activity. Several recent observations clearly put forward the idea that alterations of PSD-MAGUK protein function such as alterations of PSD-MAGUK protein interaction with N-methyl-D-aspartate (NMDA) receptors regulatory subunits are common events in several CNS disorders. With this view, a better knowledge and understanding of PSD-MAGUK function as well as of the molecular events regulating PSD-MAGUK-mediated interactions in the glutamatergic synapse could lead to the identification of new pharmaceutical targets for the therapy of CNS disorders.
Similar articles
-
Delineation of additional PSD-95 binding domains within NMDA receptor NR2 subunits reveals differences between NR2A/PSD-95 and NR2B/PSD-95 association.Neuroscience. 2009 Jan 12;158(1):89-95. doi: 10.1016/j.neuroscience.2007.12.051. Epub 2008 Jan 19. Neuroscience. 2009. PMID: 18308477
-
Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins.Trends Cell Biol. 2007 Jul;17(7):343-52. doi: 10.1016/j.tcb.2007.07.005. Epub 2007 Jul 20. Trends Cell Biol. 2007. PMID: 17644382 Review.
-
Organization of postsynaptic density proteins and glutamate receptors in axodendritic and dendrodendritic synapses of the rat olfactory bulb.J Comp Neurol. 2003 Aug 25;463(3):237-48. doi: 10.1002/cne.10745. J Comp Neurol. 2003. PMID: 12820158
-
MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse.Eur J Pharmacol. 2008 May 6;585(1):147-52. doi: 10.1016/j.ejphar.2008.01.048. Epub 2008 Feb 26. Eur J Pharmacol. 2008. PMID: 18367167 Review.
-
Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.Neuron. 2006 Oct 19;52(2):307-20. doi: 10.1016/j.neuron.2006.09.012. Neuron. 2006. PMID: 17046693
Cited by
-
Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway.Neuropsychiatr Dis Treat. 2018 Aug 28;14:2191-2206. doi: 10.2147/NDT.S169099. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30214209 Free PMC article.
-
Novel approaches to increase synaptic resilience as potential treatments for Alzheimer's disease.Semin Cell Dev Biol. 2023 Apr;139:84-92. doi: 10.1016/j.semcdb.2022.03.032. Epub 2022 Mar 31. Semin Cell Dev Biol. 2023. PMID: 35370089 Free PMC article. Review.
-
Protein kinase A-phosphorylated KV1 channels in PSD95 signaling complex contribute to the resting membrane potential and diameter of cerebral arteries.Circ Res. 2014 Apr 11;114(8):1258-67. doi: 10.1161/CIRCRESAHA.114.303167. Epub 2014 Feb 28. Circ Res. 2014. PMID: 24585759 Free PMC article.
-
Analysis of synaptic gene expression in the neocortex of primates reveals evolutionary changes in glutamatergic neurotransmission.Cereb Cortex. 2015 Jun;25(6):1596-607. doi: 10.1093/cercor/bht354. Epub 2014 Jan 9. Cereb Cortex. 2015. PMID: 24408959 Free PMC article.
-
The Dual PDZ Domain from Postsynaptic Density Protein 95 Forms a Scaffold with Peptide Ligand.Biophys J. 2020 Aug 4;119(3):667-689. doi: 10.1016/j.bpj.2020.06.018. Epub 2020 Jun 26. Biophys J. 2020. PMID: 32652058 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources